Editorial: Recent advances and new biomarkers in ulcerative colitis

Tsvetelina Velikova; Xiang Xue

doi:10.3389/fmed.2023.1214882

Editorial: Recent advances and new biomarkers in ulcerative colitis

Front Med (Lausanne). 2023 May 30:10:1214882. doi: 10.3389/fmed.2023.1214882. eCollection 2023.

Authors

Tsvetelina Velikova¹, Xiang Xue²

Affiliations

¹ Medical Faculty, Sofia University St. Kliment Ohridski, Sofia, Bulgaria.
² Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM, United States.

No abstract available

Keywords: biological therapy; biomarkers; endoscopy; fecal calprotectin; mucosal inflammation; quality of life; steroid-refractory ulcerative colitis; ulcerative colitis.

Publication types

Editorial

Grants and funding

TV is a grantee of the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, project No. BG-RRP-2.004-0008-C01. XX was supported in part by the National Institutes of Health (P20 GM130422 and K01DK114390), a Research Scholar Grant from the American Cancer Society (RSG-18-050-01-NEC), and an Environmental Health and Toxicology Pilot Award from UNM Center for Native Environmental Health Equity Research (P50 MD015706).